EIP Pharma initiates phase II study of neflamapimod for the treatment of cognitive deficits in HD July 10, 2019
Preliminary interim data presented from phase I trials of Celyad's CYAD-01 and CYAD-101 July 10, 2019
New carbapenem antibiotic shows in vitro activity against MDR Gram-negative bacterial infections July 10, 2019
Primary objective met in PK/PD trial of imeglimin in patients with type 2 diabetes and CKD July 9, 2019
Ultra-broad-spectrum beta-lactamase inhibitor QPX-7728 shows early development potential July 9, 2019
Phase III study of camrelizumab in esophageal squamous cell carcinoma meets primary endpoint July 9, 2019
Aivita reports new data from ongoing phase II trial of cancer immunotherapy in glioblastoma July 9, 2019
Efficacy of SPR-206 against Gram-negative bacteria in murine thigh and lung infection models July 9, 2019
RSS